Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation

Fecal Microbiota Transplantation forClostridium difficileInfection

(2015) Dimitri Drekonja et al.   ANNALS OF INTERNAL MEDICINE

Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow

(2015) Melissa D. Docampo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

(2015) Sally Arai et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

(2015) Robert R. Jenq et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The human microbiome in hematopoiesis and hematologic disorders

(2015) V. E. Manzo et al.   BLOOD

Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma

(2015) C Mittal et al.   BONE MARROW TRANSPLANTATION

Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons

(2015) Jelena Vulevic et al.   BRITISH JOURNAL OF NUTRITION

Intestinal microbiota-related effects on graft-versus-host disease

(2015) Yusuke Shono et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Fecal Microbiota Transplantation for RefractoryClostridium difficileColitis in Solid Organ Transplant Recipients

(2014) R. J. Friedman-Moraco et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease

(2014) Ernst Holler et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

(2014) Y. Taur et al.   BLOOD

Fecal microbiota transplant after hematopoietic SCT: report of a successful case

(2014) C G de Castro et al.   BONE MARROW TRANSPLANTATION

Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study

(2014) Caroline E. Childs et al.   BRITISH JOURNAL OF NUTRITION

Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease

(2014) Lindsey G. Albenberg et al.   GASTROENTEROLOGY

Meta'omic Analytic Techniques for Studying the Intestinal Microbiome

(2014) Xochitl C. Morgan et al.   GASTROENTEROLOGY

Diet, Metabolites, and “Western-Lifestyle” Inflammatory Diseases

(2014) Alison N. Thorburn et al.   IMMUNITY

A different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractoryClostridium difficileinfection in a patient with relapsed aggressive B-cell lymphoma

(2014) Jason A. Trubiano et al.   LEUKEMIA & LYMPHOMA

Fecal Microbiota Transplantation in Inflammatory Bowel Disease

(2014) Gianluca Ianiro et al.   MEDICINE

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile

(2014) Charlie G. Buffie et al.   NATURE

A role for the gut microbiota in IBS

(2014) Stephen M. Collins   Nature Reviews Gastroenterology & Hepatology

Antioxidants Keep the Potentially Probiotic but Highly Oxygen-Sensitive Human Gut Bacterium Faecalibacterium prausnitzii Alive at Ambient Air

(2014) M. Tanweer Khan et al.   PLoS One

Complete Suppression of the Gut Microbiome Prevents Acute Graft-Versus-Host Disease following Allogeneic Bone Marrow Transplantation

(2014) Jaak M. Vossen et al.   PLoS One

Probiotics, prebiotics and the gastrointestinal tract in health and disease

(2014) Luis Vitetta et al.   INFLAMMOPHARMACOLOGY

Norovirus Gastroenteritis After Fecal Microbiota Transplantation for Treatment of Clostridium difficile Infection Despite Asymptomatic Donors and Lack of Sick Contacts

(2013) Margot Schwartz et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders

(2013) Elaine Y. Hsiao et al.   CELL

The intestinal microbiota and susceptibility to infection in immunocompromised patients

(2013) Ying Taur et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Faecalibacterium prausnitzii and human intestinal health

(2013) S Miquel et al.   CURRENT OPINION IN MICROBIOLOGY

Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection

(2013) Rodrigo Quera et al.   Journal of Crohns & Colitis

Diet rapidly and reproducibly alters the human gut microbiome

(2013) Lawrence A. David et al.   NATURE

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

(2013) Koji Atarashi et al.   NATURE

Sequence-Based Discovery of Bradyrhizobium enterica in Cord Colitis Syndrome

(2013) Ami S. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

(2013) P. M. Smith et al.   SCIENCE

Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut

(2013) Elaine O Petrof et al.   Microbiome

Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection

(2012) Matthew J Hamilton et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis

(2012) Luis Alberto Fernández-Carrocera et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition

Nutritional support in patients with GVHD of the digestive tract: state of the art

(2012) B S van der Meij et al.   BONE MARROW TRANSPLANTATION

Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties

(2012) Jean-Michel Lecerf et al.   BRITISH JOURNAL OF NUTRITION

Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

(2012) Ying Taur et al.   CLINICAL INFECTIOUS DISEASES

Immunonutrition: Does It Have a Role in Improving Recovery in Patients Receiving a Stem Cell Transplant?

(2012) Adam D. Lye et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut Microbiota

(2012) N. Kamada et al.   SCIENCE

Fecal microbiota transplantation for fulminantClostridium difficileinfection in an allogeneic stem cell transplant patient

(2012) K. Neemann et al.   Transplant Infectious Disease

Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind study

(2012) Michel Dapoigny   WORLD JOURNAL OF GASTROENTEROLOGY

Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial: Table 1

(2011) Marie Joossens et al.   GUT

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease

(2011) J. L. Benjamin et al.   GUT

Efficacious outcome employing fecal bacteriotherapy in severe Crohn’s colitis complicated by refractory Clostridium difficile infection

(2011) C. A. Duplessis et al.   INFECTION

Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD

(2010) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

(2010) J. L. Round et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era

(2009) Geoffrey A. Preidis et al.   GASTROENTEROLOGY

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

(2009) Kendle M. Maslowski et al.   NATURE

A microbial symbiosis factor prevents intestinal inflammatory disease

(2008) Sarkis K. Mazmanian et al.   NATURE

A mixture ofEscherichia coli(DSM 17252) andEnterococcus faecalis(DSM 16440) for treatment of the irritable bowel syndrome - A randomized controlled trial with primary care physicians

(2008) p. enck et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Preterm Infants: A Multicenter, Randomized, Controlled Trial

(2008) H.-C. Lin et al.   PEDIATRICS

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women

(2008) Yue-Xin Yang et al.   WORLD JOURNAL OF GASTROENTEROLOGY